If anyone missed it, go to the Lpath website, upcoming events, and click for the replay, you have to register but fake name and email is fine, (I put one letter in each field).
You have to fast forward to 2:30 unless you want to hear all the other stuff and the bad music.
Scott's presentation skill is not the best. It is quite disheartening to listen to a CEO who is not a better speaker than me. Too many pauses. Other than that, info presented was fine. Still a very long wait for us all. Bad thing about Pfizer deal is that Lpath is not at liberty to release partial trial results even in scientific meetings. I wish somebody asked him about that. Lpathomab is still in a very early stage, but all Lpathomab research results should be used in PRs since we won't hear anything about Isonep/Asonep. It's really odd that Pfizer imposed a news blackout since other companies usually release prelim results all the time for ph1/ph2 trials.
I'm still hoping we get announcements on huge insider purchases.
I was listening for the comment about "a dozen (or did he say a half dozen) companies interested in Lpathomab" and did not hear it on the replay. Maybe I missed it, or possible there was a glitch in the recording, wondering if anyone else knows?